A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sanofi stock. As of the latest transaction made, Citadel Advisors LLC holds 722,600 shares of SNY stock, worth $34.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
722,600
Previous 377,600 91.37%
Holding current value
$34.9 Million
Previous $18.3 Million 127.42%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$48.54 - $58.53 $2.43 Million - $2.94 Million
50,150 Added 39.98%
175,593 $10.1 Million
Q2 2024

Aug 14, 2024

BUY
$45.39 - $50.36 $3.29 Million - $3.66 Million
72,582 Added 137.31%
125,443 $6.09 Million
Q1 2024

May 15, 2024

SELL
$45.75 - $52.48 $3,202 - $3,673
-70 Reduced 0.13%
52,861 $2.57 Million
Q4 2023

Feb 14, 2024

BUY
$43.13 - $54.79 $1.69 Million - $2.15 Million
39,232 Added 286.39%
52,931 $2.63 Million
Q3 2023

Nov 14, 2023

BUY
$50.95 - $55.2 $688,232 - $745,641
13,508 Added 7072.25%
13,699 $734,000
Q2 2023

Aug 14, 2023

SELL
$50.45 - $57.18 $4.53 Million - $5.14 Million
-89,812 Reduced 99.79%
191 $10,000
Q1 2023

May 15, 2023

BUY
$45.86 - $54.45 $1.29 Million - $1.53 Million
28,111 Added 45.42%
90,003 $4.9 Million
Q4 2022

Feb 14, 2023

SELL
$38.86 - $48.55 $12.9 Million - $16.2 Million
-333,233 Reduced 84.34%
61,892 $3 Million
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $8.8 Million - $23.8 Million
236,347 Added 148.85%
395,125 $15 Million
Q2 2022

Aug 15, 2022

BUY
$48.99 - $57.46 $3.78 Million - $4.43 Million
77,093 Added 94.38%
158,778 $7.94 Million
Q1 2022

May 16, 2022

SELL
$48.48 - $53.65 $3.95 Million - $4.37 Million
-81,474 Reduced 49.94%
81,685 $4.19 Million
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $4.45 Million - $4.95 Million
94,472 Added 137.54%
163,159 $8.17 Million
Q3 2021

Nov 15, 2021

SELL
$47.89 - $53.12 $6.13 Million - $6.8 Million
-128,097 Reduced 65.1%
68,687 $3.31 Million
Q2 2021

Aug 16, 2021

SELL
$49.36 - $54.25 $6.5 Million - $7.14 Million
-131,616 Reduced 40.08%
196,784 $10.4 Million
Q1 2021

May 17, 2021

BUY
$45.46 - $50.51 $40,368 - $44,852
888 Added 0.27%
328,400 $16.2 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $51.62 $5.92 Million - $6.75 Million
-130,713 Reduced 28.53%
327,512 $15.9 Million
Q3 2020

Nov 16, 2020

BUY
$49.47 - $53.77 $4.99 Million - $5.42 Million
100,874 Added 28.23%
458,225 $23 Million
Q2 2020

Aug 14, 2020

BUY
$42.91 - $52.5 $595,805 - $728,962
13,885 Added 4.04%
357,351 $18.2 Million
Q1 2020

May 15, 2020

BUY
$38.02 - $51.66 $1.38 Million - $1.88 Million
36,337 Added 11.83%
343,466 $15 Million
Q4 2019

Feb 14, 2020

BUY
$44.25 - $50.86 $5.58 Million - $6.42 Million
126,175 Added 69.73%
307,129 $15.4 Million
Q3 2019

Nov 14, 2019

BUY
$40.34 - $46.64 $6.91 Million - $7.99 Million
171,283 Added 1771.1%
180,954 $8.38 Million
Q2 2018

Aug 10, 2018

SELL
$37.63 - $41.22 $923,778 - $1.01 Million
-24,549 Reduced 71.74%
9,671 $0
Q1 2018

May 11, 2018

SELL
$38.98 - $45.76 $457,508 - $537,085
-11,737 Reduced 25.54%
34,220 $1.37 Million
Q4 2017

Feb 09, 2018

BUY
$42.86 - $50.61 $1.97 Million - $2.33 Million
45,957
45,957 $1.98 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.